Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03717532 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03717532 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 1 participants.
The verdict
NCT03717532, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.
Interventions
- PROCEDURE Placebo
- PROCEDURE Personalized Tourniquet System for Blood Flow Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03717532
The ClinicalTrials.gov registry entry for NCT03717532 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03717532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03717532 about?
NCT03717532 is a clinical study titled "Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome". The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.
What is the current status of trial NCT03717532?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-02-01. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT03717532?
The interventions under investigation include: Placebo (PROCEDURE), Personalized Tourniquet System for Blood Flow Restriction (PROCEDURE).
Who is sponsoring clinical trial NCT03717532?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.